Search

Your search keyword '"KAUL, RISHEEK"' showing total 29 results
Start Over Author "KAUL, RISHEEK"
29 results on '"KAUL, RISHEEK"'

1. Left Atrial Appendage Closure: What Do We Know?

Author

Babapoor-Farrokhran, Savalan, Alzubi, Jafar, Port, Zachary, Kaul, Risheek, Rasekhi, Roozbeh Tarighati, Farrokhran, Ali Babapour, Sooknanan, Naveen, Wiener, Philip C., Khraisha, Ola, Frishman, William H., Mainigi, Sumeet K., and Aronow, Wilbert S.

Published
2023
Full Text
View/download PDF

12. Myocarditis following COVID-19 vaccination

Author

Kaul, Risheek, Sreenivasan, Jayakumar, Goel, Akshay, Malik, Aaqib, Bandyopadhyay, Dhrubajyoti, Jin, Chengyue, Sharma, Mala, Levine, Avi, Pan, Stephen, Fuisz, Anthon, Cooper, Howard A., and Panza, Julio A.

Published
2021
Full Text
View/download PDF

19. Extracorporeal Membrane Oxygenation in Patients With COVID-19

Author

Sreenivasan, Jayakumar, primary, Ranka, Sagar, additional, Lahan, Shubham, additional, Abu-Haniyeh, Ahmed, additional, Li, Heyi, additional, Kaul, Risheek, additional, Malik, Aaqib, additional, Aronow, Wilbert S., additional, Frishman, William H., additional, and Lansman, Steven, additional

Published
2021
Full Text
View/download PDF

20. Brugada syndrome clinical update

Author

Rojas, Rhadames, primary, Kaul, Risheek, additional, Frenkel, Daniel, additional, Hoch, Ethan G, additional, Iwai, Sei, additional, Jacobson, Jason T, additional, and Aronow, Wilbert S., additional

Published
2021
Full Text
View/download PDF

22. Hotter? Yes. Faster? Yes. Better? Maybe.

Author

Kaul, Risheek and Barbhaiya, Chirag R.

Subjects
*ESOPHAGEAL injuries, *MEDICAL thermometry, *RADIO frequency therapy, *ATRIAL fibrillation, *CATHETER ablation, *RISK assessment, *PULMONARY veins, *PATIENT safety, SURGICAL complication risk factors
Abstract

The authors discuss an in vivo porcine study, published in the issue, in which epicardially implanted thermocouples were used to investigate tissue temperatures close to the Q-DOT Micro catheter during 90 W/4s lesions, very high-power short duration (vHPSD), compared to ablation index guided 50 W HPSD lesions both targeting a contact force or 8-15 g. Topics include vHPSD lesions analyzed in the study, the design of the Q-DOT Micro ablation catheter and finding on the lethal tissue temperature.

Published
2023
Full Text
View/download PDF

23. Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion.

Author

Sae Morita, Malik, Aaqib H., Toshiki Kuno, Tomo Ando, Kaul, Risheek, Yandrapalli, Srikanth, Briasoulis, Alexandros, Morita, Sae, Kuno, Toshiki, and Ando, Tomo

Subjects
HEART assist devices, HEART failure, LEFT heart atrium, ARRHYTHMIA, PATIENT readmissions, CARDIOVASCULAR diseases, CORONARY artery bypass, ATRIAL fibrillation treatment, CHRONIC kidney failure complications, STROKE, GASTROINTESTINAL hemorrhage, ATRIAL fibrillation, RETROSPECTIVE studies, TREATMENT effectiveness, HEART atrium, DISEASE complications
Abstract

Objective: Percutaneous left atrial appendage occlusion (LAAO) is an alternative strategy for prevention of thromboembolic events in patients with atrial fibrillation and unsuitable for long-term oral anticoagulation. The study aimed to evaluate the causes and timing of readmissions within 6 months following percutaneous LAAO in a real-world setting.Methods: We conducted a retrospective cohort study of percutaneous LAAO performed in the USA between January and June of 2016-2018 using the Nationwide Readmissions Database.Results: Overall, 12 446 patients who underwent LAAO were included in the analyses and 3477 patients (28%) were readmitted within 6 months following the interventions. Readmitted patients were more often women (p=0.001). The index hospitalisation was characterised by longer duration of hospital stay (p<0.001) and complicated with acute kidney injury (p<0.001) among readmitted patients compared with those without readmissions. Readmissions within 6 months following the index intervention were mainly due to heart failure (13%) and gastrointestinal bleeding (12%). Characteristics associated with readmissions due to heart failure included previously known heart failure (HR 2.39; 95% CI 1.70 to 3.37), valvular heart disease (HR 1.39; 95% CI 1.05 to 1.84) and chronic kidney disease (HR 1.42; 95% CI 1.03 to 1.94). Readmissions due to gastrointestinal bleeding were associated with diabetes mellitus (HR 1.78; 95% CI 1.25 to 2.53), chronic kidney disease (HR 1.86; 95% CI 1.23 to 2.81) and previous anaemia (HR 2.41; 95% CI 1.54 to 3.77).Conclusions: After percutaneous LAAO, over a quarter of the patients in the USA required rehospitalisation within 6 months, mainly due to heart failure and gastrointestinal bleeding. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

24. Cardiovascular Risk Factors and Complications in Patients Infected with COVID-19: A Systematic Review

Author

Sreenivasan, Jayakumar, primary, Khan, Muhammad Shahzeb, additional, Anker, Stefan D., additional, Kaul, Risheek, additional, Khan, Safi U, additional, Metra, Marco, additional, Senni, Michele, additional, Cooper, Howard A., additional, Zhang, Yuhui, additional, Zhang, Jian, additional, Fonarow, Gregg C., additional, and Butler, Javed, additional

Published
2020
Full Text
View/download PDF

27. Analysis of outcome of 6-month readmissions after percutaneous left atrial appendage occlusion

Author

Morita, Sae, Malik, Aaqib H, Kuno, Toshiki, Ando, Tomo, Kaul, Risheek, Yandrapalli, Srikanth, and Briasoulis, Alexandros

Abstract

ObjectivePercutaneous left atrial appendage occlusion (LAAO) is an alternative strategy for prevention of thromboembolic events in patients with atrial fibrillation and unsuitable for long-term oral anticoagulation. The study aimed to evaluate the causes and timing of readmissions within 6 months following percutaneous LAAO in a real-world setting.MethodsWe conducted a retrospective cohort study of percutaneous LAAO performed in the USA between January and June of 2016–2018 using the Nationwide Readmissions Database.ResultsOverall, 12 446 patients who underwent LAAO were included in the analyses and 3477 patients (28%) were readmitted within 6 months following the interventions. Readmitted patients were more often women (p=0.001). The index hospitalisation was characterised by longer duration of hospital stay (p<0.001) and complicated with acute kidney injury (p<0.001) among readmitted patients compared with those without readmissions. Readmissions within 6 months following the index intervention were mainly due to heart failure (13%) and gastrointestinal bleeding (12%). Characteristics associated with readmissions due to heart failure included previously known heart failure (HR 2.39; 95% CI 1.70 to 3.37), valvular heart disease (HR 1.39; 95% CI 1.05 to 1.84) and chronic kidney disease (HR 1.42; 95% CI 1.03 to 1.94). Readmissions due to gastrointestinal bleeding were associated with diabetes mellitus (HR 1.78; 95% CI 1.25 to 2.53), chronic kidney disease (HR 1.86; 95% CI 1.23 to 2.81) and previous anaemia (HR 2.41; 95% CI 1.54 to 3.77).ConclusionsAfter percutaneous LAAO, over a quarter of the patients in the USA required rehospitalisation within 6 months, mainly due to heart failure and gastrointestinal bleeding.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results